Anika Therapeutics, Inc.ANIKNASDAQ
Loading
Year-over-year net income growth rate
Latest
112.54%
↑ 113% vs avg
Percentile
P92
Near historical high
Streak
2 qtr
Consecutive growthAccelerating
Average
-892.19%
Historical baseline
| Period | Value |
|---|---|
| Q4 2025 | 112.54% |
| Q3 2025 | 41.34% |
| Q2 2025 | 18.53% |
| Q1 2025 | 77.71% |
| Q4 2024 | 26.92% |
| Q3 2024 | -33897.73% |
| Q2 2024 | 98.05% |
| Q1 2024 | 92.83% |
| Q4 2023 | -858.03% |
| Q3 2023 | -139.91% |
| Q2 2023 | 73.52% |
| Q1 2023 | -110.88% |
| Q4 2022 | -17.56% |
| Q3 2022 | -46.85% |
| Q2 2022 | 3.07% |
| Q1 2022 | 49.37% |
| Q4 2021 | -1138.17% |
| Q3 2021 | -91.46% |
| Q2 2021 | 130.13% |
| Q1 2021 | 118.13% |
| Q4 2020 | -144.21% |
| Q3 2020 | 16.83% |
| Q2 2020 | -233.06% |
| Q1 2020 | 43.00% |
| Q4 2019 | -55.97% |
| Q3 2019 | -2.49% |
| Q2 2019 | 109.34% |
| Q1 2019 | -41.60% |
| Q4 2018 | 1.55% |
| Q3 2018 | -24.70% |
| Q2 2018 | 250.93% |
| Q1 2018 | -182.88% |
| Q4 2017 | 17.13% |
| Q3 2017 | -39.42% |
| Q2 2017 | 106.97% |
| Q1 2017 | -32.06% |
| Q4 2016 | -9.68% |
| Q3 2016 | 3.91% |
| Q2 2016 | 24.95% |
| Q1 2016 | -37.56% |